Curaleaf launches hostile take-over bid for Aurora Cannabis at US$4.00/share, 45% premium

Curaleaf Holdings, Inc.

Offer: 0.3463 Curaleaf shares + US$0.75 cash per Aurora share, total US$4.00; 45% premium to 30-day VWAP of US$2.75.
Aurora board refused to engage after June 23 and July 7, 2026 letters from Curaleaf CEO Boris Jordan.
Combined company: 17 countries, >US$1.5B LTM revenue, ~US$350M LTM Adjusted EBITDA, pro forma market cap ~US$3.0B.
At least US$40M annual cost synergies expected; adds Aurora's 50+ tons of EU-GMP cultivation capacity.
Offer not subject to financing or due diligence conditions; 105-day acceptance period; no formal bid commenced yet.

Featured in Daily 8-K Digest

Selected #3 for 2026-08-12. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.